17.89
+0.48(+2.76%)
Currency In USD
| Previous Close | 17.41 |
| Open | 17.3 |
| Day High | 17.9 |
| Day Low | 17.2 |
| 52-Week High | 23.64 |
| 52-Week Low | 4.37 |
| Volume | 1.62M |
| Average Volume | 3.69M |
| Market Cap | 4.23B |
| PE | 66.26 |
| EPS | 0.27 |
| Moving Average 50 Days | 18.86 |
| Moving Average 200 Days | 13.7 |
| Change | 0.48 |
If you invested $1000 in ADMA Biologics, Inc. (ADMA) 10 years ago, it would be worth $1,611.71 as of December 26, 2024 at a share price of $17.89. Whereas If you bought $1000 worth of ADMA Biologics, Inc. (ADMA) shares 5 years ago, it would be worth $4,417.28 as of December 26, 2024 at a share price of $17.89.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
GlobeNewswire Inc.
Dec 20, 2024 12:00 PM GMT
Cash on Hand Utilized to Repay $30 Million of Senior Secured Term Loan Facility to Ares Capital Lowers ADMA’s Total Debt to $75 Million, a 29% Reduction Further Supports Earnings Growth Outlook RAMSEY, N.J. and BOCA RATON, Fla., Dec. 20, 2024 (GLO
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.
Nov 07, 2024 9:05 PM GMT
3Q 2024 Total Revenue of $119.8 Million, a 78% Increase Y-o-Y 3Q 2024 GAAP Net Income of $35.9 Million, a 1,300% Increase Y-o-Y 3Q 2024 Adjusted EBITDA(1) of $45.4 Million, a 256% Increase Y-o-Y KPMG LLP Engaged as New Independent Registered Publi
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
GlobeNewswire Inc.
Oct 29, 2024 8:10 PM GMT
Conference Call Scheduled for November 7, 2024, at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company de